Pharmaceutical Syrup Formulation Enhancing Bioavaibility and Patient Compliance

Year : 2025 | Volume : | : | Page : –
By
vector

Mohd. Wasiullah,

vector

Piyush Yadav,

vector

Akash Yadav,

  1. Principal, Dept. of Pharmacy, Prasad Institute Technology, Jaunpur, Uttar Pradesh, India
  2. Professor & Head, Dept. of Pharmaceutical Chemistry, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  3. Students, Dept. of Pharmacy, Prasad Polytechnic, Jaunpur, Uttar Pradesh, India

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_149411’);});Edit Abstract & Keyword

Pharmaceutical syrup formulations are crucial for drug delivery, especially in pediatric and geriatric populations. However, challenges such as bioavailability, stability, and patient compliance due to factors like taste and viscosity must be addressed. Strategies to enhance bioavailability include solubility enhancers, nanoparticle systems, and advanced techniques like solid dispersions and emulsions. Palatability plays a critical role in patient compliance, with flavoring agents, sweeteners, and texture modifications improving acceptability. Innovations like controlled-release formulations and the use of nanotechnology are advancing syrup efficacy. Regulatory aspects and case studies provide insights into successful formulations, while emerging research explores personalized medicine applications in syrup delivery systems.

Keywords: Palatibility, bioavaibility, Gastrointestinal, micronization, therapeutics.

How to cite this article:
Mohd. Wasiullah, Piyush Yadav, Akash Yadav. Pharmaceutical Syrup Formulation Enhancing Bioavaibility and Patient Compliance. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2025; ():-.
How to cite this URL:
Mohd. Wasiullah, Piyush Yadav, Akash Yadav. Pharmaceutical Syrup Formulation Enhancing Bioavaibility and Patient Compliance. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2025; ():-. Available from: https://journals.stmjournals.com/rrjodfdp/article=2025/view=0

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_149411’);});Edit

References

1. Golhen, K, Buettcher M, Kost J, Huwyler J, Pfister M. Meeting challenges of pediatric drug delivery: the potential of orally fast disintegrating tablets for infants and children. Pharmaceutics. 2023 Mar 23;15(4):1033, https://doi.org/10.3390/pharmaceutics15041033.

2. Spadoni C. Pediatric Drug Development: Challenges and Opportunities. Curr Ther Res Clin Exp. 2018 Dec 28;90:119-122. doi: 10.1016/j.curtheres.2018.12.001.

3. Lou J, Duan H, Qin Q, Teng Z, Gan F, Zhou X, Zhou X. Advances in Oral Drug Delivery Systems: Challenges and Opportunities. Pharmaceutics. 2023 Feb 1;15(2):484. doi: 10.3390/pharmaceutics15020484.

4. Allen LV Jr. Dosage form design and development. Clin Ther. 2008 Nov;30(11):2102-11. doi: 10.1016/j.clinthera.2008.11.015.

5. Yamashita F, Hashida M. In silico approaches for predicting ADME properties of drugs. Drug Metab Pharmacokinet. 2004 Oct;19(5):327-38. doi: 10.2133/dmpk.19.327.
6. Carstensen, J. T., Drug stability: principles and practices. Drugs and the pharmaceutical sciences. 1990;43:X-520.

7. Fahelelbom KM, El-Shabrawy Y. Analysis of preservatives in pharmaceutical products. Pharm. Rev. 2007;5:1-55.

8. VandenBerg CJ, Adams A, Bockrath R, Kim S, Rodriguez G, Fawcett A, Jhaveri R. Hard to Swallow: A Review of Interventions to Improve Swallowing Solid Medication. Hospital Pediatrics. 2023 May 1;13(5):e123-32.
9. Engel, J., C Heckler, C. E. (2018). “Sensory and patient-centered formulation development.” Advanced Drug Delivery Reviews, 136, 1-17.

10. Shahiwala A. Formulation approaches in enhancement of patient compliance to oral drug therapy. Expert opinion on drug delivery. 2011 Nov 1;8(11):1521-9.

11. Bhalani DV, Nutan B, Kumar A, Singh Chandel AK. Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics. Biomedicines. 2022 Aug 23;10(9):2055. doi: 10.3390/biomedicines10092055.

12. Aqil F, Munagala R, Jeyabalan J, Vadhanam MV. Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett. 2013 Jun 28;334(1):133-41. doi: 10.1016/j.canlet.2013.02.032.
13. Douroumis D. Practical approaches of taste masking technologies in oral solid forms. Expert opinion on drug delivery. 2007 Jul 1;4(4):417-26.

14. Chauhan R. Taste masking: A unique approach for bitter drugs. Journal of stem cell biology and transplantation. 2017;1(2):12-20.
15. Shahiwala A. Formulation approaches in enhancement of patient compliance to oral drug therapy. Expert opinion on drug delivery. 2011 Nov 1;8(11):1521-9.

16. Mu Y, Zhao L, Shen L. Medication adherence and pharmaceutical design strategies for pediatric patients: An overview. Drug Discovery Today. 2023 Sep 12:103766.

17. CM, Jîtcă G, Ősz BE, Pușcaș A, Imre S. Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient’s Safety—A Narrative Review. Pharmaceutics. 2023 Apr 21;15(4):1306.–1315.

18. Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A. Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients. Pharmaceutics. 2019 Apr 18;11(4):190. doi: 10.3390/pharmaceutics11040190.

19. Marques L, Costa B, Pereira M, Silva A, Santos J, Saldanha L, Silva I, Magalhães P, Schmidt S, Vale N. Advancing precision medicine: A review of innovative In Silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics. 2024 Feb 27;16(3):332.

20. Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, Ramirez BI, Sánchez-Guirales SA, Simon JA, Tomietto G, Rapti C. Artificial intelligence (AI) applications in drug discovery and drug delivery: Revolutionizing personalized medicine. Pharmaceutics. 2024 Oct 14;16(10):1328.


Ahead of Print Subscription Review Article
Volume
Received 14/12/2024
Accepted 30/12/2024
Published 20/01/2025